All ABBV Content

AbbVie (ABBV) TD Cowen 46th Annual Health Care Conference

AbbVie (NYSE: ABBV) FY 2026 Corporate Conference

February 24, 20261 min read

AbbVie (ABBV) AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States

AbbVie (NYSE: ABBV) FY 2026 Other Release

February 23, 20261 min read

AbbVie (ABBV) Sec Form 10K

AbbVie (NYSE: ABBV) Sec Form 10K

February 22, 20261 min read

AbbVie (ABBV) U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)

AbbVie (NYSE: ABBV) FY 2026 Other Release

February 20, 20261 min read

AbbVie (ABBV) Dividend Update

AbbVie (NYSE: ABBV) Q1 2026 Dividend Update

February 19, 20261 min read

Analysis

S&P 500 Gains as Risk-On Rotation Sends Energy Up 1.84%, Utilities Down 1.68%

S&P 500 gains 0.52% as energy surges 1.84% and tech adds 1.34%, while utilities tumble 1.68% in risk-on rotation.

February 19, 20263 min read

AbbVie (ABBV) Q4 2025 Earnings Call

AbbVie (NYSE: ABBV) Q4 2025 Earnings Conference

February 17, 20261 min read

AbbVie (ABBV) Q2 2025 Earnings Call Transcript

AbbVie (NYSE: ABBV) Q2 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Liz Shea — Senior Vice President, Investor Relations Robert A. Michael —…

January 22, 202650 min read

AbbVie (ABBV) Q3 2025 Earnings Call Transcript

AbbVie (NYSE: ABBV) Q3 2025 Earnings Call dated Oct. 31, 2025 Corporate Participants: Liz Shea — Senior Vice President of Investor Relations Robert A. Michael…

January 22, 202662 min read

AlphaGraphs

Key highlights from AbbVie’s (ABBV) Q2 2025 earnings results

AbbVie (NYSE: ABBV) reported its second quarter 2025 earnings results today. Worldwide net revenues were $15.4 billion, up 6.6% on a reported basis, or 6.5%…

July 31, 20251 min read